Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giovanna Sfriso
Institutions:
University of Verona,
Azienda Ospedaliera Universitaria Integrata Verona
Observed institutions:
University of Verona,
Azienda Ospedaliera Universitaria Integrata Verona
ORCID:
0009-0001-2059-4470
Observed ORCID:
0009-0001-2059-4470
OpenAlex ID:
A5120086542
Development of Betalactam‐Predictor: A Clinical Decision Tool for Delabeling Low‐Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy
2026
·
Marina Labella
, Rafael Nuñez
, et al.
·
Allergy
·
7
PDF
Safety and efficacy of extended venom immunotherapy maintenance intervals in mastocytosis
2025
·
Giovanna Sfriso
, Matteo Martini
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
2
New Insights Into Immunomodulatory Strategies for Drug Hypersensitivity Reactions: An EAACI Task Force Report
2026
·
Ana Maria Copaescu
, Valentina Gueli
, et al.
·
Clinical and Translational Allergy
·
1
Venom immunotherapy in children and adolescents: Efficacy and safety in an Italian tertiary allergy center
2026
·
Valentina Gueli
, Francesca Norelli
, et al.
·
Pediatric Allergy and Immunology
PDF
Safety of Venom Immunotherapy in Pregnancy: A Multicentre Study
2026
·
Matteo Martini
, Giovanna Sfriso
, et al.
·
Allergy
PDF
Author response for "Venom immunotherapy in children and adolescents: efficacy and safety in an Italian tertiary allergy center"
2026
·
Valentina Gueli
, Francesca Norelli
, et al.
·
Publons reviews and discussion
Safety of Drug Provocation Tests in Adults With and Without Clonal Mast Cell Disorders
2025
·
Francesca Nalin
, Bianca Olivieri
, et al.
·
Allergy
Show more works
View as search
Works count:
7
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type